One of the most common genetic changes found in AML patients is FLT3. Dr. Nicholas Short from MD Anderson Cancer Center will explain how they affect treatment decisions and what targeted therapies are available today.

HealthTree Foundation offers trusted education, community support, and a powerful patient data portal for Acute Myeloid Leukemia (AML) patients.

Join our newsletter to stay informed of future AML webinars https://htree.org/amlnews

Follow HealthTree
https://x.com/HealthTree
Instagram: healthtreeforaml
Facebook: HealthTreeForAML